← Open Payments lookup

NPI 1437145471: Open Payments

NPI 1437145471. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$281 in 10 payments from 5 companies in 2025. Trend: 2023 $846 · 2024 $538 · 2025 $281

Food & beverage: $281
CompanyPaymentsAmount
Axsome Therapeutics, Inc.3$150
Otsuka America Pharmaceutical, Inc.3$54
Takeda Pharmaceuticals U.S.A., Inc.2$33
Janssen Pharmaceuticals, Inc1$26
Corium, LLC1$18

Products named: Auvelity, REXULTI, TRINTELLIX, SPRAVATO, Azstarys.